MILLENNIUM PHARMACEUTICALS INC 3
3 · Day One Biopharmaceuticals, Inc. · Filed May 26, 2021
Insider Transaction Report
Form 3
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Holdings
- 6,470,382(indirect: See Explanation of Responses)
Common Stock
Footnotes (2)
- [F1]This statement is being filed jointly by Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc.
- [F2]Takeda Pharmaceutical Company Limited's beneficial ownership of the reported securities is comprised of 6,470,382 shares of Common Stock held by Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc., is a direct, wholly owned subsidiary of Takeda Pharmaceuticals U.S.A. Inc., which is a direct subsidiary of Takeda Pharmaceutical Company Limited (72.70%) and Takeda Pharmaceuticals International AG (27.3%). Takeda Pharmaceuticals International AG is a direct, wholly owned subsidiary of Takeda Pharmaceutical Company Limited.